malondialdehyde has been researched along with dynorphins in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Hong, X; Zheng, L | 1 |
| Chen, M; Cheng, Y; Du, S; Fan, J; Ma, S; Qu, H; Shi, J; Sun, H; Yao, Q; Zhan, S; Zhang, M; Zhang, X | 1 |
2 other study(ies) available for malondialdehyde and dynorphins
| Article | Year |
|---|---|
[Changes of dynorphinA1-13 on the treatment of hypoxic-ischemic brain injury by the brain-derived neurotrophic factor in neonatal rats].
Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Dynorphins; Female; Hypoxia-Ischemia, Brain; Male; Malondialdehyde; Oxygen; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2002 |
Dynorphin A (1-8) inhibits oxidative stress and apoptosis in MCAO rats, affording neuroprotection through NMDA receptor and κ-opioid receptor channels.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Caspase 3; Dynorphins; Infarction, Middle Cerebral Artery; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa; Superoxide Dismutase | 2021 |